Your SlideShare is downloading. ×
0
SCA interim report Q2 2012
SCA interim report Q2 2012
SCA interim report Q2 2012
SCA interim report Q2 2012
SCA interim report Q2 2012
SCA interim report Q2 2012
SCA interim report Q2 2012
SCA interim report Q2 2012
SCA interim report Q2 2012
SCA interim report Q2 2012
SCA interim report Q2 2012
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

SCA interim report Q2 2012

3,271

Published on

Published in: Business, Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
3,271
On Slideshare
0
From Embeds
0
Number of Embeds
3
Actions
Shares
0
Downloads
5
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Interim Report1 January – 30 June 2012
  • 2. Q2 2012Macro update Global economy and private consumption to slow in 2012  Debt crisis in parts of Western Europe has a negative impact  Emerging markets shows relatively good growth Hygiene products  Good growth in Emerging markets  Low or no growth in Western Europe and North America Forest products  Lower European demand and unacceptably low prices in publication paper  Continued weak demand and unsatisfactory low prices in solid-wood products  Price increases for Kraftliner during Q22 Interim Report Q2 2012
  • 3. Q2 2012Closed five important deals Acquisition of Georgia-Pacific’s European tissue operations Acquisition of Everbeauty an Asian hygiene products company Increased shareholding in Vinda Acquisition of PISA in Chile Divestment of the Packaging business, excluding the two kraftliner mills3 Interim Report Q2 2012
  • 4. SummaryQ2 2012 vs Q2 2011 Sales increased 2%*  Hygiene business  Higher volumes  Higher prices  Good growth in emerging markets • Personal Care, 20%** • Tissue, 17%**  Forest Products  Lower volumes  Lower prices EBIT increased 16%***  Higher volumes  Lower raw material and energy costs* Excluding exchange rate movements and divestment** Excluding exchange rate movements*** Excluding items affecting comparability , exchange rate movements and divestments4 Interim Report Q2 2012
  • 5. Q2 2012 resultsSEK millions Q2 Q2 Change, Change, unless otherwise stated 2012 2011 % %**Net sales 20,273 20,415 -1 2EBIT* 2,105 1,810 16 16EBIT margin* (%) 10.4 8.9Profit before tax* 1,789 1,527 17Earnings per share (SEK) 1.85 1.96Operating cash flow 2,391 1,868Debt/Equity ratio 0.41 0.55* Excluding items affecting comparability** Excluding exchange rate movements, and divestments5 Interim Report Q2 2012
  • 6. Q2 2012 vs. Q1 2012Summary Group  Sales increased 4%  EBIT increased 15%* Business areas  Personal Care, EBIT increased 17%* • Higher volumes • Improved product mix  Tissue, EBIT increased 10%* • Higher volumes • Lower energy costs • Higher raw material costs  Forest Products, EBIT increased 31%* • Higher prices • Lower volumes • Lower raw material and energy costs* Excluding items affecting comparability6 Interim Report Q2 2012
  • 7. Personal CareQ2 2012 vs. Q2 2011 6,530  Sales increased 7% (+10%*) 6,116  Incontinence care increased 9%* 7%  Baby diapers increased 14%*  Feminine care increased 8%*  Emerging markets increased 20%**SALES SEKm Q212 Q211 781  EBIT increased 34%*** (41%****) 34%*** 582  Higher volumes  Improved product mix  Cost savings  Lower raw material costsEBIT*** SEKm Q212 Q211EBIT margin*** 12.0% 9.5%* Excluding exchange rate movements and divestments** Excluding exchange rate movements*** Excluding items affecting comparability**** Excluding items affecting comparability, exchange rate movements and divestments7 Interim Report Q2 2012
  • 8. TissueQ2 2012 vs. Q2 2011 9,461 9,609  Sales decreased 2% (+4%*)  Consumer tissue increased 5%* -2%  AFH tissue increased 2%*  Emerging markets increased 17%**  EBIT increased by 53%*** (45%****)SALES SEKm Q212 Q211  Higher prices 1,021  Improved product mix  Lower raw material costs 53% 668  Cost savingsEBIT*** SEKm Q212 Q211EBIT margin*** 10.8% 7.0%* Excluding exchange rate movements and divestments** Excluding exchange rate movements*** Excluding items affecting comparability**** Excluding items affecting comparability and exchange rate movements 8 Interim Report Q2 2012
  • 9. Forest ProductsQ2 2012 vs. Q2 2011  Sales decreased 9% 4,868 5,322  Publication papers, decreased sales • Lower volumes -9%  Solid-wood products, flat sales • Higher volumes • Lower pricesSALES SEKm Q212 Q211  Kraftliner, decreased sales • Lower prices • Higher volumes 659  Pulp, decreased sales 433 • Lower prices and volumes -34%*  EBIT decreased 34%*EBIT* SEKm Q212 Q211  Lower pricesEBIT margin* 8.9% 12.4%  Higher raw material costs* Excluding items affecting comparability9 Interim Report Q2 2012
  • 10. Q&A10 Interim Report Q2 2012

×